These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
495 related items for PubMed ID: 31216830
1. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma]. Lyu L, Liu Y, Wang XY, Zhang ZK, Tao XL, Yang L, Wu N. Zhonghua Zhong Liu Za Zhi; 2019 Jun 23; 41(6):441-447. PubMed ID: 31216830 [Abstract] [Full Text] [Related]
4. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Kaseda K, Asakura K, Kazama A, Ozawa Y. World J Surg; 2016 Dec 23; 40(12):2976-2983. PubMed ID: 27456499 [Abstract] [Full Text] [Related]
5. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Park HK, Jeon K, Koh WJ, Suh GY, Kim H, Kwon OJ, Chung MP, Lee KS, Shim YM, Han J, Um SW. Respirology; 2010 Nov 23; 15(8):1179-84. PubMed ID: 20573058 [Abstract] [Full Text] [Related]
6. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study. Miao H, Shaolei L, Nan L, Yumei L, Shanyuan Z, Fangliang L, Yue Y. Thorac Cancer; 2019 Jun 23; 10(6):1453-1460. PubMed ID: 31127706 [Abstract] [Full Text] [Related]
7. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma. Moon SH, Kim HS, Hyun SH, Choi YS, Zo JI, Shim YM, Lee KH, Kim BT, Choi JY. J Nucl Med; 2014 May 23; 55(5):743-8. PubMed ID: 24700884 [Abstract] [Full Text] [Related]
12. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study. Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J, Kozuka T, Hosoki T, Hasegawa Y, Takami M, Tomita Y, Kodama K. Lung Cancer; 2011 Mar 23; 71(3):333-7. PubMed ID: 20619479 [Abstract] [Full Text] [Related]
13. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma. Kayata H, Isaka M, Terada Y, Mizuno K, Yasuura Y, Kojima H, Ohde Y. Gen Thorac Cardiovasc Surg; 2019 Jun 23; 67(6):544-550. PubMed ID: 30627979 [Abstract] [Full Text] [Related]
14. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer. Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J. Clin Lung Cancer; 2013 Sep 23; 14(5):568-73. PubMed ID: 23835164 [Abstract] [Full Text] [Related]
16. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. Ye B, Cheng M, Li W, Ge XX, Geng JF, Feng J, Yang Y, Hu DZ. Ann Thorac Surg; 2014 Jul 23; 98(1):217-23. PubMed ID: 24841547 [Abstract] [Full Text] [Related]
18. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT. Li S, Zheng Q, Ma Y, Wang Y, Feng Y, Zhao B, Yang Y. PLoS One; 2013 Jul 23; 8(10):e78552. PubMed ID: 24205256 [Abstract] [Full Text] [Related]